Biomeditsina va amaliyot jurnali, 2022 №6
Тема статьи
MORPHOMETRIC AND PLOIDOMETRIC STUDIES OF BREAST CANCER AND THEIR PROGNOSTIC SIGNIFICANCE (189-195)
Авторы
Alimkhodzhaeva T. Lola, Bozorova M. Lutfiya.
Учреждение
Republican Specialized Scientific and Practical medical center of oncology and radiology
Аннотация
This article describes the indicators of DNA content in the nuclei of cell suspensions during flow cytophotometry, which differ significantly from the results of photometry of histological and cytological preparations stained according to Feulgen. With flow photometry, the amount of DNA is measured not only in the nuclei of epithelial cells in neoplasia, but also in the nuclei of cells in the stroma, blood vessels, and other structures. These conditions of flow photometry significantly change the nature of the histograms of the distribution of nuclei, as a rule, towards the predominance of the diploid peak due to the nuclei of non-tumor cells. If monoclonal antibody "tags" are used in flow cytometry to detect the cell population of interest, then in this case the result of the study may also be unreliable, since monoclonal antibodies can be expressed both in carcinomas and in benign tumors and normal breast tissue. When diagnosing the last stage, the degree of differentiation of carcinoma is determined by ploidy values. The ploidy of cell nuclei 4.5-5.4s indicates the first, highly differentiated degree, 5.5-6.4s the second, moderately differentiated degree, 6.5-7.4s - the third, lowdifferentiated. Thus, this research method makes it possible to clarify the diagnosis of the stages of carcinogenesis in the mammary gland and make informed decisions regarding benign processes, borderline conditions, and malignant neoplasms. The data obtained can be used as additional differential diagnostic criteria for morphological diagnosis of the stages of carcinogenesis in the mammary gland.
Ключевые слова
Breast cancer, carcinogenesis, diagnosis, prognostic factors.
Литературы
Андреасян Г. О., Преображенская Т. М. Стереометрический анализ местной иммунной реактивности эпителиальных опухолей яичников // Успехи теоретической и клинической медицины. - М., РМАПО, 2019. - С. 46 - 47. 2. Гельштейн В. И., Чипышева Т. А, Ермилова В. Д., Любимов А. В. Моноклональные антитела к белкам промежуточных филаментов и базальных мембран в дифференциальной диагностике некоторых форм опухолей молочных желез человека // - Арх. пат. - 2020. - № 9. - С. 12. 3. Гланц С. Медико - биологическая статистика: Пер. с англ.- М.: Практика, 2018.-459 с. 4. Головин Д. И. Атлас опухолей человека. - Л., Медицина, 2000. — 318с. 5. TNM классификация злокачественных опухолей / Под ред. Блинова Н. Н. - С. - Пб.: Эскулап, 2008. - 191 с. 6. Трапезников Н. Н., Летягин В. П., Алиев Д. А. Лечение опухолей молочной железы. - М.: Медицина, 2018. — 175 с. 7. Упоров А. В., Семиглазов В. Ф., Пожарисский К. М. Иммуногистохимическое изучение клеток рака молочной железы с использованием разных маркеров пролиферации // Арх. патол. - 2000. - №2. - С. 26 - 30. 8. Botstwick D. J., Brawer M. K. Prostatic intraepithelial neoplasia and early invasion in prostate // Cancer. - 2001. - Vol. - 59. - P. 788 - 794. 9. Chano Т., Kontani K., Teramoto K., Okabe H., et. al. Truncating mutations of RB 1 CC1 in human breast cancer // Nat. Genet. - 2020 - Vol. 31. - P. 285 - 288. 10. Gustafsson A., Tartter P. I., Brower S. Т., Lesnick G. Prognosis of patients with bijateral carcinoma of the breast // J. Am. Coll. Surg. - 2021. - Vol. 178.-P. 111-116. 11. Haagensen с D., Lane N., Lattes R. Neoplastic proliferation of the epithelium of the mammary lobules: adenosis, lobular neoplasia, and small cell carcinoma // Surg. Clin. North. Am. - 2022. - Vol. 52. - P. 497 - 524. 12. Oyama Т., Kashiwabara K., Yoshimoto K., et al. Frequent overexpression of the cyclin D 1 oncogene in invasive lobular carcinoma of the breast // Cancer Res. - 2018. - Vol. 58. - P. 2876 - 2880. №6 | 2022 195 13. Page D. L., Kidd T. E. Jr., Dupont W. D., et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease//Hum. Pathol.- 2021.-Vol. 22.- P. 1232-1239. 14. Rozan S., Vincent-Salomon A., Zafrani В., et al. No significant predictive value of с - erbB - 2 or p 53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer //Int. J. Cancer. -2019. - Vol. 79. - P. 27-33. 15. Sandritter W. Cytophotometrie — Methoden und Zytophotometrie // Acta Histochem. - 2022. - Bd 26. -Р. 35 - 46. 16. Steinbeck R. G. Mitotic failure and genome stability in benign, premalignant an$ malignant human tissues // Karolinska Inst. Hospit. Stockholm. - 2000.-P. 220. 17. Tavassoli F. A. Mammary intraepithelial neoplasia: a translational classification system for the intraductal epithelial proliferation // Breast J. - 2017. - Vol. 3. - P. 48 - 58. 18. Yunusova L. et al. Magnetic resonance imaging in the diagnosis of cystic lesions of the neck //Annals of Cancer Research and Therapy. – 2021. – Т. 29. – №. 1. – С. 102-109. 19. Rizaev, J. A., and A. I. Khazratov. "Цитоструктурное изменение слизистой оболочке полости рта при раке толстой кишки." Journal of Biomedicine and Practice 6.5 (2020). 20. Ризаев Ж. А., Хазратов А. И. Канцерогенное влияние 1, 2–диметилгидразина на организм в целом //Биология. – 2020. – Т. 1. – С. 116. 21. Shakhanova Shakhnoza, Rakhimov Nodir, Zaripova Parvina. Breast tumors in adolescent girls // Journal of Biomedicine and Practice. 2022, vol. 7, issue 3, pp.266-273 22. Lutfillo Yorov, Mirjalol Djuraev, Nodir Raximov, Shakhnoza Shakhanova. Evaluation of the state of the immune status in patients with breast cancer with the determination of the effectiveness of neoadjuvant polychemotherapy. Journal of Biomedicine and Practice. 2022, vol. 7, issue 5, pp.211-216